Company profile for Theolytics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establi...
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Innovation Building Roosevelt Drive Oxford England OX3 7FZ
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/13/3165321/0/en/Theolytics-to-Present-Ongoing-Phase-I-IIa-OCTOPOD-IV-Trial-of-THEO-260-in-Ovarian-Cancer-at-ESMO-2025.html

GLOBENEWSWIRE
13 Oct 2025

https://www.globenewswire.com/news-release/2025/10/07/3162239/0/en/Theolytics-Appoints-Experienced-Medical-Oncologist-Matilde-Saggese-MD-as-Chief-Medical-Officer.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2024/12/17/2998000/0/en/Theolytics-Appoints-David-Apelian-MD-PhD-MBA-as-CEO.html

GLOBENEWSWIRE
17 Dec 2024

https://www.globenewswire.com/news-release/2024/11/19/2983294/0/en/Theolytics-Doses-First-Patient-in-Phase-I-IIa-Trial-of-THEO-260-in-Ovarian-Cancer.html

GLOBENEWSWIRE
19 Nov 2024

https://www.globenewswire.com/news-release/2024/09/02/2938919/0/en/Theolytics-Awarded-Significant-2M-Transforming-Cancer-Therapeutics-Grant-from-Innovate-UK.html

GLOBENEWSWIRE
02 Sep 2024

https://www.globenewswire.com/news-release/2024/04/17/2864255/0/en/Theolytics-successfully-closes-latest-financing-raising-total-of-19M-24-5M-and-welcomes-Sound-Bioventures-as-new-investor.html

GLOBENEWSWIRE
17 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty